AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33671235 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue whiting-derived protein hydrolysate (BWPH)
Number of subjects: 7
Study 33671235 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI)
Number of subjects: 7
Study 33671235 — intervention group
Group type: COMPARATOR
Intervention: Non-essential amino acid (NEAA) control
Number of subjects: 7
Study 33262331 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV-based therapy
Number of subjects: 1053
Study 33262331 — intervention group
Group type: EXPERIMENTAL
Intervention: DTG-based therapy
Number of subjects: 1053
Study 33262331 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cohort
Number of subjects: 1053
Study 35939436 — intervention group
Group type: COMPARATOR
Intervention: Two-finger technique (2FT)
Number of subjects: 3
Study 35939436 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-thumb encircling technique (2TT)
Number of subjects: 3
Study 35939436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-thumb technique (CTT)
Number of subjects: 3
Study 35331537 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised nutrition therapy including 5 home visits and 3 phone calls, energy- and protein-rich foods, and oral nutrition supplements for six months.
Number of subjects: 106
Study 35331537 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 106
Study 32078512 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored occupation-based intervention administered for 7 weeks in individual 1-hour sessions, focusing on routine establishment, organization, time management, stress management, and sensory regulation.
Number of subjects: 23
Study 32078512 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study 35854212 — intervention group
Group type: EXPERIMENTAL
Intervention: ddPCR assay
Number of subjects: 2292
Study 35854212 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 2292
Study 34086002 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 102
Study 34086002 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine with epinephrine and dexamethasone
Number of subjects: 102
Study 32885808 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/day pitavastatin for 12 weeks
Number of subjects: 34
Study 32885808 — intervention group
Group type: COMPARATOR
Intervention: 10 mg/day atorvastatin for 12 weeks
Number of subjects: 34
Study 35090047 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1327
Study 35090047 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 1327
Study 35090047 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at weeks 6, 12, 18, and 24)
Number of subjects: 1327
Study 35090047 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at 6 weeks)
Number of subjects: 1327
Study 35090047 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment LDH (elevated at 12 weeks)
Number of subjects: 1327
Study 33577375 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) therapy; 8 sessions applied during cardiac rehabilitation (CR).
Number of subjects: 34
Study 33577375 — intervention group
Group type: COMPARATOR
Intervention: Schultz' Autogenic Training; 8 sessions applied during cardiac rehabilitation (CR).
Number of subjects: 34
Study 32386511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses using CDSS
Number of subjects: 1294
Study 32386511 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians with different medical specialties
Number of subjects: 1294
Study 32386511 — intervention group
Group type: COMPARATOR
Intervention: GPs
Number of subjects: 1294
Study 33933012 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone treatment starting with 60 mg daily tapered over 8 weeks
Number of subjects: 110
Study 33933012 — intervention group
Group type: COMPARATOR
Intervention: No prednisolone treatment (control group)
Number of subjects: 110
Study 32084431 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) injection
Number of subjects: 18
Study 32084431 — intervention group
Group type: COMPARATOR
Intervention: Acipimox (anti-lipolytic agent)
Number of subjects: 18
Study 32084431 — intervention group
Group type: COMPARATOR
Intervention: GH-receptor antagonist
Number of subjects: 18
Study 33144346 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-tailored intervention
Number of subjects: 501
Study 33144346 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-tailored intervention
Number of subjects: 501
Study 33144346 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 501
Study 32379635 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon inhalation aromatherapy
Number of subjects: 100
Study 32379635 — intervention group
Group type: COMPARATOR
Intervention: Paraffin (Control)
Number of subjects: 100
Study 35553043 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC-GED 5%
Number of subjects: 450
Study 35553043 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC-GED 2%
Number of subjects: 450
Study 35553043 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 450
Study 34324430 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 56
Study 34324430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 56
Study 33175624 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycologic infection detection kit
Number of subjects: 136
Study 35313227 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (800 mg IV in 150 mL normal saline over 5 minutes)
Number of subjects: 99
Study 35313227 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (800 mg IV in 150 mL normal saline over 5 minutes)
Number of subjects: 99
Study 33837491 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-wearable sensor
Number of subjects: 1000
Study 33837491 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000
Study 35500536 — intervention group
Group type: EXPERIMENTAL
Intervention: Anle138b (dose range 50 mg to 300 mg per day)
Number of subjects: 68
Study 35500536 — intervention group
Group type: EXPERIMENTAL
Intervention: Anle138b (multiple doses of 200 mg)
Number of subjects: 68
Study 35500536 — intervention group
Group type: EXPERIMENTAL
Intervention: Anle138b (150 mg per day)
Number of subjects: 68
Study 35500536 — intervention group
Group type: COMPARATOR
Intervention: Placebo (excipient only)
Number of subjects: 68
Study 33738583 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridged one-anastomosis gastric bypass (BOAGB)
Number of subjects: 44
Study 32814582 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain arabinoxylan (25 g/day for females; 35 g/day for males)
Number of subjects: 31
Study 32814582 — intervention group
Group type: COMPARATOR
Intervention: Microcrystalline cellulose (non-fermentable control)
Number of subjects: 31
Study 35323040 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 days of beta-lactam treatment
Number of subjects: 171
Study 35323040 — intervention group
Group type: COMPARATOR
Intervention: 10 days of beta-lactam treatment
Number of subjects: 171
Study 32722370 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerostipes
Number of subjects: 0
Study 32722370 — intervention group
Group type: EXPERIMENTAL
Intervention: Desulfovibrio spp.
Number of subjects: 0
Study 32722370 — intervention group
Group type: COMPARATOR
Intervention: Acidaminococcus, Bacteroides, Bifidobacterium, Faecalibacterium, Lactobacillus, Megamonas
Number of subjects: 0
Study 35176141 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of CHIP in SLE patients
Number of subjects: 573
Study 35176141 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of CHIP at inclusion
Number of subjects: 573
Study 32077731 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental emotion socialization (PES) intervention
Number of subjects: 255
Study 32077731 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 255
Study 35534364 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoliase
Number of subjects: 356
Study 35534364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study 34308815 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelfoam packing
Number of subjects: 80
Study 34308815 — intervention group
Group type: COMPARATOR
Intervention: No gelfoam packing
Number of subjects: 80
Study 32952009 — intervention group
Group type: EXPERIMENTAL
Intervention: F + V (Fruits and Vegetables)
Number of subjects: 108
Study 32952009 — intervention group
Group type: COMPARATOR
Intervention: NaHCO3 (HCO3‐)
Number of subjects: 108
Study 32952009 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 108
Study 32952009 — intervention group
Group type: EXPERIMENTAL
Intervention: F + V
Number of subjects: 108
Study 32952009 — intervention group
Group type: COMPARATOR
Intervention: F + V and NaHCO3 (HCO3‐)
Number of subjects: 108
Study 34990854 — intervention group
Group type: EXPERIMENTAL
Intervention: Onsite buprenorphine treatment initiation
Number of subjects: 250
Study 34990854 — intervention group
Group type: COMPARATOR
Intervention: Enhanced referral
Number of subjects: 250
Study 35380643 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment-based self-care education program
Number of subjects: 236
Study 35380643 — intervention group
Group type: COMPARATOR
Intervention: Didactic education program
Number of subjects: 236
Study 34229554 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus FOLFIRI
Number of subjects: 1072
Study 34229554 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus FOLFIRI
Number of subjects: 1072
Study 34229554 — intervention group
Group type: COMPARATOR
Intervention: Ramucirumab vs Placebo
Number of subjects: 1072
Study 33029118 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol levels
Number of subjects: 229
Study 33029118 — intervention group
Group type: COMPARATOR
Intervention: Low cortisol levels
Number of subjects: 229
Study 35240966 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 200 mg 3 times a day (600mg daily) plus conventional treatment
Number of subjects: 260
Study 34889650 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation
Number of subjects: 748
Study 34889650 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 748
Study 34378472 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed text messages
Number of subjects: 536
Study 34378472 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed text messages
Number of subjects: 536
Study 34364196 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who experienced IPV
Number of subjects: 1788
Study 34364196 — intervention group
Group type: COMPARATOR
Intervention: Women who did not experience IPV
Number of subjects: 1788
Study 32156204 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic blood pressure parameters (BP variability)
Number of subjects: 381
Study 32156204 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady blood pressure parameter (hypotension time with mean arterial pressure <90 mm Hg)
Number of subjects: 381
Study 34626672 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 76
Study 34626672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32823886 — intervention group
Group type: EXPERIMENTAL
Intervention: High Polyphenol Diet (HPD)
Number of subjects: 99
Study 32823886 — intervention group
Group type: COMPARATOR
Intervention: Low Polyphenol Diet (LPD)
Number of subjects: 99
Study 36576555 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac-Orphenadrine
Number of subjects: 72
Study 36576555 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 72
Study 36576555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Isotonic saline solution)
Number of subjects: 72
Study 34328848 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 detection incidental to hospitalization
Number of subjects: 346
Study 32329092 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin plus opioids
Number of subjects: 46
Study 32329092 — intervention group
Group type: COMPARATOR
Intervention: Opioids alone
Number of subjects: 46
Study 36775514 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent training (CT)
Number of subjects: 31
Study 36775514 — intervention group
Group type: COMPARATOR
Intervention: No training (Control group)
Number of subjects: 31
Study 34435694 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2%, applied once daily (QD)
Number of subjects: 81
Study 34435694 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2%, applied twice daily (BID)
Number of subjects: 81
Study 34435694 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2% (both QD and BID)
Number of subjects: 81
Study 34435694 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 81
Study 32434370 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 60
Study 32434370 — intervention group
Group type: COMPARATOR
Intervention: Local Anesthesia (LA)
Number of subjects: 60
Study 35908682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical instrumentation with adjunct photodynamic therapy (PDT)
Number of subjects: 107
Study 35908682 — intervention group
Group type: COMPARATOR
Intervention: Mechanical instrumentation without adjunct photodynamic therapy (Control)
Number of subjects: 107
Study 35908682 — intervention group
Group type: COMPARATOR
Intervention: Mechanical instrumentation without adjunct photodynamic therapy (Control) in Group 2
Number of subjects: 107
Study 35908682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical instrumentation with adjunct photodynamic therapy (PDT) in Group 2
Number of subjects: 107
Study 35908682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical instrumentation with adjunct photodynamic therapy (PDT) in Group 1
Number of subjects: 107
Study 35908682 — intervention group
Group type: COMPARATOR
Intervention: Mechanical instrumentation without adjunct photodynamic therapy (Control) in Group 1
Number of subjects: 107
Study 35908682 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical instrumentation with or without PDT
Number of subjects: 107
Study 35908682 — intervention group
Group type: COMPARATOR
Intervention: Healthy patients (Group 3)
Number of subjects: 107
Study 32145440 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte‐Macrophage Colony Stimulating Factor (GM‐CSF) 500 μg/day subcutaneously thrice weekly for three weeks, followed by a second administration after 3 months.
Number of subjects: 176
Study 32145440 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections thrice weekly for three weeks, followed by matching placebo injections after 3 months.
Number of subjects: 176
Study 35361012 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who read any type of comment posted by other users
Number of subjects: 296
Study 35361012 — intervention group
Group type: COMPARATOR
Intervention: Participants who only viewed brelfies
Number of subjects: 296
Study 32552264 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release oral milrinone
Number of subjects: 23
Study 32552264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 32838463 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 135
Study 32838463 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection (PI)
Number of subjects: 135
Study 34097710 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' experiences and health service problems
Number of subjects: 4142
Study 34097710 — intervention group
Group type: EXPERIMENTAL
Intervention: Health system limitations
Number of subjects: 4142
Study 34097710 — intervention group
Group type: COMPARATOR
Intervention: Deployment of midwives
Number of subjects: 4142
Study 34097710 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement and health system transformation
Number of subjects: 4142
Study 33960201 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 (4000 IU/d)
Number of subjects: 289
Study 33960201 — intervention group
Group type: COMPARATOR
Intervention: Low-dose vitamin D3 (400 IU/d)
Number of subjects: 289
Study 33960201 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D supplementation (both doses)
Number of subjects: 289
Study 32569164 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Chinese and Western medicine treatment group (Jiawei qianyang dan)
Number of subjects: 110
Study 32569164 — intervention group
Group type: COMPARATOR
Intervention: Western medicine treatment group
Number of subjects: 110
Study 32569164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after 1 year of follow-up
Number of subjects: 110
Study 34686815 — intervention group
Group type: EXPERIMENTAL
Intervention: AssistDent AI software
Number of subjects: 23
Study 34686815 — intervention group
Group type: COMPARATOR
Intervention: Control group without AI assistance
Number of subjects: 23
Study 32317229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime hydrating eyelid gel (TDHA-AOX and HA), applied nightly to the upper and inner eyelids of the right eye for 2 weeks
Number of subjects: 62
Study 32125880 — intervention group
Group type: EXPERIMENTAL
Intervention: IPC1talc
Number of subjects: 0
Study 32125880 — intervention group
Group type: COMPARATOR
Intervention: Symptom-guided drainage
Number of subjects: 0
Study 32125880 — intervention group
Group type: COMPARATOR
Intervention: Daily drainage
Number of subjects: 0
Study 35397250 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention (four brief videos with Black/White female and male presenters)
Number of subjects: 1993
Study 35397250 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control condition
Number of subjects: 1993
Study 33876183 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention including guidance to increase vegetables, fruit, and grains.
Number of subjects: 48835
Study 33876183 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 48835
Study 32301241 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 22
Study 32301241 — intervention group
Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 22
Study 32301241 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management and hospital management
Number of subjects: 22
Study 32301241 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid approach (brief stay in hospital and early home management)
Number of subjects: 22
Study 35235859 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training + saffron (RS)
Number of subjects: 0
Study 35235859 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (R)
Number of subjects: 0
Study 35235859 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron consumption (S)
Number of subjects: 0
Study 35235859 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 0
Study 35368792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nephrology Immersion Classroom (mobile-friendly digital blackboard videos)
Number of subjects: 0
Study 35368792 — intervention group
Group type: COMPARATOR
Intervention: Usual inpatient nephrology consult rotation (control group)
Number of subjects: 0
Study 35537502 — intervention group
Group type: EXPERIMENTAL
Intervention: T2HIGH/T17LOW group
Number of subjects: 70
Study 35537502 — intervention group
Group type: EXPERIMENTAL
Intervention: T2LOW/T17HIGH group
Number of subjects: 70
Study 35537502 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with T2 gene expression
Number of subjects: 70
Study 35537502 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin SN (CST1) expression
Number of subjects: 70
Study 34095302 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical flexor muscle training using pressure biofeedback
Number of subjects: 55
Study 34095302 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercises
Number of subjects: 55
Study 33363364 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation + Usual Care
Number of subjects: 82
Study 33363364 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Only
Number of subjects: 82
Study 33755799 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet inflated throughout the procedure
Number of subjects: 50
Study 33755799 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet used only during skin incision and cementation
Number of subjects: 50
Study 32975739 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐Fe (1000 IU/day vitamin D3 plus 27 mg/day iron)
Number of subjects: 87
Study 32975739 — intervention group
Group type: COMPARATOR
Intervention: D‐P (vitamin D3 plus placebo)
Number of subjects: 87
Study 32975739 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 87
Study 35804451 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil (SO) 30g/day for 12 weeks
Number of subjects: 60
Study 35804451 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (SFO) 30g/day for 12 weeks
Number of subjects: 60
Study 34672230 — intervention group
Group type: EXPERIMENTAL
Intervention: Sipjeondaebo-tang (SDT) 3g 3 times daily for 3 weeks
Number of subjects: 50
Study 34672230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34672230 — intervention group
Group type: EXPERIMENTAL
Intervention: Sipjeondaebo-tang (SDT)
Number of subjects: 50
Study 35230962 — intervention group
Group type: EXPERIMENTAL
Intervention: No-therapist, single-session, online intervention targeting perceived control over anxiety
Number of subjects: 522
Study 35230962 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention encouraging handwashing
Number of subjects: 522
Study 33084533 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calprotectin (SCal) levels in OSA patients
Number of subjects: 67
Study 33084533 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil/lymphocyte ratio (NLR) values in OSA patients
Number of subjects: 67
Study 33084533 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calprotectin (SCal) levels in severe OSA patients
Number of subjects: 67